The Conquer Cancer Foundation of the American Society of Clinical Oncology (ASCO) is working to improve cancer care by funding bright young researchers and studies in all types of cancer. Foundation grantees are actively performing research studies that are improving the quality of the cancer care that you, your family, and your friends or colleagues receive. In addition, the Foundation supports meetings and educational forums for physicians and other cancer professionals where these ground-breaking studies are being presented, and where health care professionals can learn new information to improve the care of their patients.
One such meeting is the Gastrointestinal Cancers Symposium, being held January 24-26, in San Francisco, California, which focuses on the latest research in gastrointestinal cancers. This year, the Foundation is supporting 25 Merit Awards in Gastrointestinal Cancer for trainees to present high-quality research at the meeting. Past grant and award recipients, such as the 10 researchers listed below, are presenting important research findings at the symposium about bile duct, esophageal, colon, gastric, liver, and rectal cancers on a wide array of topics including new treatments, new diagnostics, risk factors, and racial disparities. To view summaries of the studies and results being presented by these Foundation-funded investigators, visit the online Meeting Program after January 22, 6:00 pm ET.
The 10 Foundation grantees and their research titles are:
Daniel J. Becker, MD (2010 Young Investigator Award, or YIA) – Uptake of recommendations for adequate nodal removal in colorectal cancer resection.
Charles S. Fuchs, MD, MPH (1991 YIA) – REGARD: A phase III, randomized, double-blind trial of ramucirumab and best supportive care versus placebo and BSC in the treatment of metastatic gastric or gastroesophageal junction adenocarcinoma following disease progression on first-line platinum- and/or fluoropyrimidine-containing combination therapy.
Robin K. Kelley, MD (2010 YIA) – Circulating tumor cells in metastatic hepatocellular carcinoma: Comparison to control patients with non-malignant liver diseases and exploratory characterization by next generation sequencing.
Scott Kopetz, MD, PhD (2008 Career Development Award, or CDA) – Genomic classifiers (ColoPrint/ MSI-Print) to predict outcome and chemotherapy benefit in stage II and III colon cancer patients.
Christopher Hanyoung Lieu, MD (2010 YIA) – Increased gene copy number and amplification of FGF2 and FGFR1 in metastatic colorectal cancer.
Rebecca A. Miksad, MD, MPH (2007 YIA) – Hepatocellular cancer tumor growth and metabolic risk factors.
Zsofia Kinga Stadler, MD (2010 CDA) – Characterization of rectal cancer in patients with Lynch syndrome.
Suebpong Tanasanvimon, MD (2011 Long-term International Fellowship) – Comparison of microRNA expression profiles between opisthorchis viverrini-associated cholangiocarcinoma and non-opisthorchis viverrini-associated cholangiocarcinoma.
Neeta K. Venepalli, MD (2010 YIA) – Racial differences in patients with hepatocellular carcinoma: A large single-institution experience.
Harry H. Yoon, MD (2007 YIA) – HER2 testing in esophageal adenocarcinoma using parallel tissue-based methods.